THE EFFECT OF FIBRINOGEN INFUSION APPLIED AFTER CARDIOPULMONARY BYPASS ON BLEEDING IN CORONARY ARTERY BYPASS GRAFT SURGERY: RETROSPECTIVE COMPARATIVE STUDY
Journal Title: Kocatepe Medical Journal - Year 2022, Vol 23, Issue 4
Abstract
OBJECTIVE: The effect of administered fibrinogen concentrates in reducing the risk of postoperative bleeding that remains a serious problem in open heart surgery is controversial. We aimed to present the effect of fibrinogen concentrates on postoperative bleeding applied after cardiopulmonary bypass (CPB) in coronary artery bypass grafting (CABG). MATERIAL AND METHODS: 67 patients who underwent CABG and measured below 2.5 g / L fibrinogen after CPB were included in the study. Data of 32 patients (Group F; n=32 patients) who were given fibrinogen concentrate were compared with 35 patients (Group NF; n=35 patients) who were not given fibrinogen concentrate. RESULTS: After CPB, fibrinogen concentrate was applied to patients in order to increase fibrinogen levels to 2.5 g/L and above. For both groups, fibrinogen levels decreased significantly after CPB compared to preoperative levels (p<0.01), however, there was no difference between the groups in terms of reduction rate (p = 0.321). 2.94±0.91 g fibrinogen was administered to the patients in Group F. Postoperative drainage between the groups was not significant in both the 0-12 hour period (p=0.142) and 12-24 hour period(p = 0.309). CONCLUSIONS: Fibrinogen concentrate may reduce the amount of postoperative drainage with secondary effects which increased low plasma fibrinogen levels and contributes to recovery of coagulation physiology. However, because this decrease was not statistically significant, we think that fibrinogen concentrates should be used only in patients with a high risk of bleeding and in patients with fibrinogen levels below <1.5 g/L after CPB.
Authors and Affiliations
Ümit ARSLAN Ali İhsan TEKİN Ferhat BORULU Ziya YILDIZ Mehmet TORT Bilgehan ERKUT
Keywords
Related Articles
- EP ID EP709857
- DOI https://doi.org/10.18229/kocatepetip.986997
- Views 33
- Downloads 0
A CASE OF PEBAT SYNDROME WITH A NOVEL MUTATION IN TUBULIN-SPECIFIC CHAPERONE D (TBCD) GENE
Tubulinopathies describe a family of neurodevelopmental / neurodegenerative diseases caused by mutations in various genes encoding tubulin isoforms. Mutations in TBCD (Tubulin-Specific Chaperone D) that encodes one of th...
THE EFFECT OF PANDEMIC ON EMERGENCY DEPARTMENT AND POLYCLINIC APPLICATIONS IN THE CAPPADOCIA REGION
OBJECTIVE: With the spread of the new coranavirus disease caused by the SARS-CoV-2 virus all over the world after the city of Wuhan in China, a pandemic process has begun. In this study, we aimed to compare the patient v...
INCREASED RETICULAR FIBER GRADE IN PRIMARY IMMUNE THROMBOCYTOPENIA
OBJECTIVE: Bone marrow fibrosis in primary immune thrombocytopenia (ITP) has become a centre of attention since cases with fibrosis were reported during trombopoeitin receptor agonist therapies but, there have been few s...
ESTIMATION OF THE INFRAORBITAL FORAMEN LOCATION USING MORPHOMETRIC ANALYSIS
OBJECTIVE: Determining/ Identifying the localization of the infraorbital foramen (IOF) and its relationship with surrounding structures have great importance for many clinical disciplines. It is suggested that supraorbit...
MOLECULAR PATHWAYS THAT PLAY A ROLE IN THE PREECLAMPSIA PATHOPHYSIOLOGY
Preeclampsia (PE) is an obstetric disease seen in approximately 4-5% of pregnancies progressing with hypertension and urinary proteinuria. It may cause maternal and fetal complications. Despite numerous researches in the...